KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
C

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of Neoadjuvant Therapy and Checkpoint Inhibitors

By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
1,616 views
August 2, 2019
Comments 1
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
Lung
15:47

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of…

KU Hematology & Medical Oncology Review 2019

C. Langer

1.6K views
22:33

KU ASCO 2019 Review of Recurrent / Metastatic NSCLC: Wild Type, KN00…

KU Hematology & Medical Oncology Review 2019

C. Langer

900 views